These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

121 related items for PubMed ID: 16974200

  • 1. Use of long-acting risperidone in the treatment of bipolar patients.
    Savas HA, Yumru M, Ozen ME.
    J Clin Psychopharmacol; 2006 Oct; 26(5):530-1. PubMed ID: 16974200
    [No Abstract] [Full Text] [Related]

  • 2. The use of risperidone in the treatment of bipolar disorder.
    Schaffer CB, Schaffer LC.
    J Clin Psychiatry; 1996 Mar; 57(3):136. PubMed ID: 8617699
    [No Abstract] [Full Text] [Related]

  • 3. Risperidone long-acting injection as monotherapy and adjunctive therapy in the maintenance treatment of bipolar I disorder.
    Fagiolini A, Casamassima F, Mostacciuolo W, Forgione R, Goracci A, Goldstein BI.
    Expert Opin Pharmacother; 2010 Jul; 11(10):1727-40. PubMed ID: 20486830
    [Abstract] [Full Text] [Related]

  • 4. Usefulness of long-acting injectable risperidone during 12-month maintenance therapy of bipolar disorder.
    Han C, Lee MS, Pae CU, Ko YH, Patkar AA, Jung IK.
    Prog Neuropsychopharmacol Biol Psychiatry; 2007 Aug 15; 31(6):1219-23. PubMed ID: 17532106
    [Abstract] [Full Text] [Related]

  • 5. Risperidone for the treatment of acute mania in children and adolescents with bipolar disorder: a randomized, double-blind, placebo-controlled study.
    Haas M, Delbello MP, Pandina G, Kushner S, Van Hove I, Augustyns I, Quiroz J, Kusumakar V.
    Bipolar Disord; 2009 Nov 15; 11(7):687-700. PubMed ID: 19839994
    [Abstract] [Full Text] [Related]

  • 6. Association between antipsychotic combination therapy and treatment adherence among individuals with bipolar disorder.
    Gianfrancesco FD, Sajatovic M, Tafesse E, Wang RH.
    Ann Clin Psychiatry; 2009 Nov 15; 21(1):3-16. PubMed ID: 19239828
    [Abstract] [Full Text] [Related]

  • 7. Two cases of bipolar disorder successfully stabilized for five years with a low dose of risperidone and lithium.
    Yoshimura R, Ueda N, Shinkai K, Nakamura J.
    Pharmacopsychiatry; 2006 Nov 15; 39(6):233-4. PubMed ID: 17124648
    [Abstract] [Full Text] [Related]

  • 8. Depot risperidone in the outpatient management of bipolar disorder: a 2-year study of 10 patients.
    Malempati RN, Bond DJ, Yatham LN.
    Int Clin Psychopharmacol; 2008 Mar 15; 23(2):88-94. PubMed ID: 18301123
    [Abstract] [Full Text] [Related]

  • 9. Oral versus injectable antipsychotic treatment in early psychosis: post hoc comparison of two studies.
    Emsley R, Oosthuizen P, Koen L, Niehaus DJ, Medori R, Rabinowitz J.
    Clin Ther; 2008 Dec 15; 30(12):2378-86. PubMed ID: 19167596
    [Abstract] [Full Text] [Related]

  • 10. Comparative clinical responses to risperidone and divalproex in patients with pediatric bipolar disorder.
    MacMillan CM, Withney JE, Korndörfer SR, Tilley CA, Mrakotsky C, Gonzalez-Heydrich JM.
    J Psychiatr Pract; 2008 May 15; 14(3):160-9. PubMed ID: 18520785
    [Abstract] [Full Text] [Related]

  • 11. Switching to long-acting injectable risperidone is beneficial with regard to clinical outcomes, regardless of previous conventional medication in patients with schizophrenia.
    Marinis TD, Saleem PT, Glue P, Arnoldussen WJ, Teijeiro R, Lex A, Latif MA, Medori R.
    Pharmacopsychiatry; 2007 Nov 15; 40(6):257-63. PubMed ID: 18030649
    [Abstract] [Full Text] [Related]

  • 12. [Use of Hunperdal Richter in psychiatry].
    Magyar GI, Fadgyas I.
    Neuropsychopharmacol Hung; 2009 Jun 15; 11(2):111-5. PubMed ID: 19827319
    [Abstract] [Full Text] [Related]

  • 13. Long-acting injectable risperidone in a bipolar patient submitted to bariatric surgery and intolerant to conventional mood stabilizers.
    Brietzke E, Lafer B.
    Psychiatry Clin Neurosci; 2011 Mar 15; 65(2):205. PubMed ID: 21414098
    [No Abstract] [Full Text] [Related]

  • 14. Risperidone treatment of bipolar disorder.
    McIntyre R, Young LT, Hasey G, Patelis-Siotis I, Jones BD.
    Can J Psychiatry; 1997 Feb 15; 42(1):88-90. PubMed ID: 9040930
    [No Abstract] [Full Text] [Related]

  • 15. [Long-acting injectable risperidone in treatment resistant borderline personality disorder. A small series report].
    Díaz-Marsá M, Galian M, Montes A, Fernández R, Arza R, López-Ibor J, Carrasco J.
    Actas Esp Psiquiatr; 2008 Feb 15; 36(2):70-4. PubMed ID: 18365787
    [Abstract] [Full Text] [Related]

  • 16. Use of long-acting risperidone in psychiatric disorders: focus on efficacy, safety and cost-effectiveness.
    Keith S.
    Expert Rev Neurother; 2009 Jan 15; 9(1):9-31. PubMed ID: 19102665
    [Abstract] [Full Text] [Related]

  • 17. A long-term prospective study on the outcome of bipolar patients treated with long-acting injectable risperidone.
    Vieta E, Nieto E, Autet A, Rosa AR, Goikolea JM, Cruz N, Bonet P.
    World J Biol Psychiatry; 2008 Jan 15; 9(3):219-24. PubMed ID: 18609430
    [Abstract] [Full Text] [Related]

  • 18. Use of risperidone long-acting injection to support treatment adherence and mood stabilization in pediatric bipolar patients: a case series.
    Fu-I L, Boarati MA, Stravogiannis A, Wang YP.
    J Clin Psychiatry; 2009 Apr 15; 70(4):604-6. PubMed ID: 19403102
    [No Abstract] [Full Text] [Related]

  • 19. Antipsychotic agents and bipolar disorder.
    Tohen M, Zarate CA.
    J Clin Psychiatry; 1998 Apr 15; 59 Suppl 1():38-48; discussion 49. PubMed ID: 9448668
    [Abstract] [Full Text] [Related]

  • 20. Effect of risperidone on plasma catecholamine metabolites and brain-derived neurotrophic factor in patients with bipolar disorders.
    Yoshimura R, Nakano Y, Hori H, Ikenouchi A, Ueda N, Nakamura J.
    Hum Psychopharmacol; 2006 Oct 15; 21(7):433-8. PubMed ID: 17029305
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.